share_log

北水加仓药明生物超5亿港元,甩卖华润电力;南水卖出东方财富超3亿元

Wuxi Biologics increased his position in Beishui by more than HK $500m and sold China Resources Power Holdings on sale; Nanshui sold Oriental wealth of more than 300m yuan.

Moomoo News ·  Feb 16, 2022 17:58

On Wednesday, southbound Capital bought a net HK $366 million today, ending its fourth consecutive net sale. Wuxi Biologics, CNOOC Limited and Semiconductor Manufacturing International Corporation received a net purchase of HK $552 million, HK $199 million and HK $141 million respectively. In terms of net sales, China Resources Power Holdings, Industrial and Commercial Bank of China and China Construction Bank Corporation received net sales of HK $877 million, HK $407 million and HK $273 million respectively.

On Wednesday, Beixiang Capital sold a net sale of 1.623 billion yuan for the whole day, making a cumulative net sale of 8.956 billion yuan for three consecutive days. It is worth mentioning that Shenzhen Stock Exchange, represented by technology stocks, sold 2.574 billion yuan again today, having sold net for 10 consecutive days, and creating the longest continuous net sale since its opening in December 2016, indicating that foreign investors are relatively cautious about high valuation plates. Shanghai Stock Connect received a net purchase of 951 million yuan.

The amount of net buying and selling of active stocks in inland stock market is relatively small. Gem heavyweights were collectively sold off, including Oriental Wealth net sales of 313 million yuan, Ningde era, Mindray Medical net sales of more than 200 million yuan. In addition, Yongtai Technology and GE's shares sold more than 100 million yuan, while CITIC sold nearly 100 million yuan.

In terms of net purchase, China Merchants Bank and Huichuan bought more than 300 million yuan, while Wuliangye, Zijin Mining Group and China Zhongjie bought more than 100 million yuan.

Edit / somer

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment